| Breakdown | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 325.90M | 361.00M | 342.65M | 264.10M | 230.11M |
| Gross Profit | 179.60M | 203.90M | 194.59M | 136.91M | 116.93M |
| EBITDA | 54.40M | 50.20M | 55.25M | 38.54M | 32.68M |
| Net Income | 27.00M | 25.40M | 32.30M | 20.24M | 16.89M |
Balance Sheet | |||||
| Total Assets | 364.50M | 385.30M | 371.74M | 315.11M | 289.24M |
| Cash, Cash Equivalents and Short-Term Investments | 44.00M | 40.60M | 65.75M | 51.54M | 41.23M |
| Total Debt | 29.80M | 32.40M | 8.90M | 10.65M | 12.23M |
| Total Liabilities | 148.60M | 170.50M | 169.29M | 127.28M | 120.27M |
| Stockholders Equity | 215.90M | 214.80M | 202.45M | 187.84M | 168.97M |
Cash Flow | |||||
| Free Cash Flow | 38.90M | 35.70M | 31.78M | 20.26M | 31.86M |
| Operating Cash Flow | 40.30M | 41.90M | 37.62M | 26.88M | 39.85M |
| Investing Cash Flow | -8.90M | -69.90M | -4.61M | -6.87M | -30.90M |
| Financing Cash Flow | -26.30M | 3.20M | -16.93M | -12.77M | -22.99M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | £504.91M | 7.41 | 10.70% | 3.26% | -9.72% | 6.25% | |
74 Outperform | £43.88B | 12.61 | 90.85% | 2.13% | 1.65% | 8.61% | |
65 Neutral | £6.78B | 9.76 | 9.26% | 2.32% | 0.70% | -22.05% | |
63 Neutral | £286.43M | 5.69 | 3.57% | 0.53% | -8.41% | -51.11% | |
62 Neutral | £159.69M | -0.29 | -21.91% | 11.37% | -3.75% | -346.47% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | £10.32B | 32.17 | 0.87% | 2.34% | 13.74% | -95.47% |